Thank afternoon, you very everyone. good much, David, and
to discuss and making to balance recapping quarter the we’re I’ll sheet then fiscal our additional outlook balance and I’ll XXXX liquidity. we’ve our of taken I’ll the our the then achieve progress start improve XXXX. by and review sheet delever profitability. results, fiscal the actions including priorities for first balance
results. begin our first ‘XX fiscal quarter Let’s with
across reflected additional growth point inflection our by key end generate the to a track as cost million and of delivered of to of achieve our reductions remain P&L. transformation $XXX QX million all revenue fiscal businesses, cost We undertaken year significant view current results firmly over virtually the improvement past profitability we’ve we across savings year. $XXX on Overall, as business in and
consolidated we last up of revenue QX Looking results, million year. $XXX at financial of is to compared our net X% in delivered which QX,
on except revenue showing & of XX% Excluding were increased basis. QX X% was a XXX% gross businesses, Storz margin of up year-over-year. BioSteel, divestiture, all revenue was which impact net XX%. up retail the year-over-year Drivers BioSteel Bickel growth and improvement with for
on. and QX adding depreciation XX%, relative $XX over back to cash, we EBITDA and loss of an gross a QX approximately was E&O flow fiscal $XX EBITDA I’ll loss $XXX non-cash an later BioSteel, to estimate in in adjusted XX%, BioSteel. gross Excluding margin outflow QX detail BioSteel. ‘XX. excluding improvement to margin of of of non-recurring was attributable We included cash expenses, million was which million, million, which speak items, more over adjusted was few XX% estimate Free was
quarter detail. a to the million, key $XX revenue QX now Canada, Starting like was our of of in sequential a increase. with revenue second more I’d review row in businesses net results
quarter, was business and BXB strong was the down our from up adult-use by flower year, compared to compared but Tweed to led growth products. prior Our X% XX% pre-rolled last
our was year. compared margin, margin and the medical across sales and cash business back and of E&O savings versus adding was cultivations, to Canadian was indirect was Gross COGS costs actions estimated expenses depreciation year The implemented, X% transformation as reduction including and by cost non-cash our plan. increased facility driven gross last part improvement and X% XX%. manufacturing negative cost costs, distribution an direct last
cost further gross in We margins. improvement reductions expect drive additional to
end X exit the Following our of facility Hershey full July. at main of
as ‘XX. CBD Rest in business. cannabis of revenue down fiscal increased a bulk but versus included XX% sales of sale sales as U.S. year’s million Israel, to the QX Last a opportunistic $X.X one-time were well the world year-over-year, XX% crude
geographic mix an post was with margin our business margin shift, to Gross sales offset last reflecting a year’s CBD shift bulk XX%, high-margin U.S. Israel. our improvement by by strategy partially boosted in
cannabis estimated look XX%, when So in margin delivered you at QX. million, margin of and revenue our cash gross total, we an XX% of of business gross $XX in
Turning to U.S. improved sales performance. Storz Bickel. non-cannabis, with saw primarily year-over-year, to starting revenue its growth by return growing in XX% QX driven with S&B &
U.S. impacted challenges by As you XXXX recall, our certain partners. sales fiscal in at part negatively financial distribution in were
resources, several an key expanded year margin sales we’ve of improvement the by U.S. Over to the driven ago, enhanced XX% vaporizers saw driving in a & distribution XX% the months, is gross in U.S. compared this and the S&B Bickel U.S. our course higher and our additional past Storz of presence to effort market. with
product increased benefiting care contributions This at Gross sales from margin line. its remains Works grew from body its healthy year-over-year, XX%. X%s
performance BioSteel. and Let in saw QX, up a more into velocity strong spend by club during me selling ahead by than XXX% this over of believe an from outsized Saw modest increased on revenue QX drove quarter, greater We our mass sponsorship, NHL the show of brand driven driven distribution growth season. million key growth. Canada. BioSteel $XX increased shipments BioSteel channel of food, drug, which minutes awareness couple expected now summer to will
higher costs also expenses SG&A in QX increase its costs of fiscal that margin in costs, aging warehousing by due at repair in inventory, which last as began year. and year, E&O due quarter facility. was manufacturing as higher to AMP certain last Verona destruction product sponsorship to an second of Gross came at and expenses costs, driven saw higher BioSteel maintenance inventory XX%, of the a NHL spend to impacted by negative the compared well the
across As the call, we’ve of to and BioSteel we which improve a the both spend cost reduce number implemented last reduce gross said at the margins AMP expected to coming our in actions quarters. P&L in are
in negative fiscal QX plan, $X subsidy ago. transformation last of progress margin, cost driven our by was business and million path-to-profitability. spend me the million Let million. partially $XX million EBITDA we’re a a speak loss improvement year now making a to reduction year’s million BioSteel’s offset a increase ‘XX by compared lapping gross of from on decline $XX AMP adjusted which $XX the was is The in million $XX payroll $X benefit BioSteel’s to
Looking and compared R&D selling at to $XX a by a marketing, closely, ago. our SG&A G&A expenses expenses more and declined million or XX% combined year
marketing, investments R&D declined selling increased and year-over-year. G&A $XX million in BioSteel, and Excluding by or expenses XX%
acquisition, Our costs driver BioSteel’s the costs $X $X by other million over historical divestiture of million with financials. is of million, biggest related $X the increased and increase restatement to to the of
our and to like cash now review I’d sheet. flow balance
million the $XXX June $XXX at Our cash quarter cash end end. investment short-term reflecting million, net a of quarter March was outflow and from balance
due of an a outflow payments, cash million, cash litigation its outflow accounts in payments. interest sales million including $XXX cash $XX BioSteel $XXX first approximately million in increase also $XX included this working cash of saw and million outflow an included several recur. in quarter growth, the capital to in we restructuring cash operations Breaking outflow million, flow an receivables. was cash to payments including not did QX was increase And non-recurring from expect $XX the related that down costs
operations exit our reduction to be FYXX, as in of cost We cash line completion our by we from the expect with program. BioSteel excluding interest driven flow our roughly expenses
we disposition part an activities, our of closed facilities $XX transformation plan. inflow within -- transformation flow Second, investing business as cash saw from that of from million QX of
financing in asset We proceeds sales of for outflow $XXX of from the $XXX agreement the XXXX, million resulted continue proceeds that an related $XXX expect the lease total of before to secure second Debt in activities pay-down the loan to September Quebec up million senior October and to JV $XX additional termination financing the payments during we end of following million. QX of exited. relates net pay-down of other to the the term million for activity
of improve XX, Subsequent of had June additional quarter-end, Turning a XXXX, $XXX we’ve and We to $XXX as and balance million $X.XXX strengthen settled actions cash debt the sheet, investments, billion. in we full to to taken balance the and liquidity. short-term the total million sheet which $XX the September annual principal amount into million post convertible of $XX notes paying and unsecured and remaining million we XXXX equitize notes equity, in our a July in shareholder $XXX the the into of we’re new exchanging refinancing note, cash. meeting expect to million
secured of We senior this cash reduce loan. of [ph] removed covenant a minimum the payment made $XX to liquidity amount million $XXX million and loan term principal the we for term for under $X.XX and the dollar,
track total of on on generate million will We dollar. term the proceeds XX% also to of which at of a down $XXX remain of to September, $X.XX to be up net end the pay used by loan proceeds
in $XXX total equity, debt short-term balance minimal the is settled decline held actions approximately note Constellation following million estimate that So obligation. debt we with to promissory of will completion the and these by assuming our
strengthen annual our over reduced million additional our interest current to executable a of to by cash expenses And million addition, to to million would months approximately improve expected financial on $XX going coming number $XX continue rates, that that be liquidity. work interest and In the we are to forward. $XX next $XX at position in resulting million savings options are
revenue our reduction we’re run key achieve the and In as on priorities fiscal remainder current to path balance of I’d ‘XX. profitability like cost at to a program. now provide achieving we the Canada for firmly outlook of cannabis, rate
gummies in back addition the our to of both ‘XX. portfolio believe sales into potential of fiscal profitability our provides also half the and upside We Wana that
in expect driven flower back of new Poland and THC Germany, XX world cannabis, supply as fiscal by as performance well growth rest the In we continued improved in Australia of our half in high restore. the of
compared and to & with expected profit is sales to down Storz For Bickel, be seasonality impacted by QX. QX
However, product a and performance by the back the new U.S. on we half in launch the fall in a expect focus the in driven continued of year growth improving
modest to sales expected summer QX, again expected versus compared by to season. to post more sales and QX are patterns be down in normalize we as QX sales selling growth the show velocity Works seasonality. are BioSteel, impacted expect to shipment For QX This
cash XXXX cash our we program. interest fiscal exiting completion cost based flow From momentum a to businesses on standpoint, core expect aligned operation and from our to current our of our excluding reduction business BioSteel be expenses, across
results we demonstrate well with we the in believe QX our as exception of EBITDA we’re underway closing, XXXX target adjusted of to positive that exit So, BioSteel. achieving
and remove working initiatives and the soon as profitability underway improve several flow financial our to and cash actively also sheet are to possible, to our BioSteel toward continue position. drag as strengthen We’re for balance
I This concludes now We’ll analysts. your our take happy to David prepared and take from now questions. Operator, comments. questions are